UnitedHealth Group Incorporated $UNH Shares Sold by Annex Advisory Services LLC

Key Points

• Annex Advisory Services LLC significantly reduced its shares in UnitedHealth Group by 69.8%, selling 41,553 shares and retaining 18,018 shares valued at approximately $5.6 million.
• UnitedHealth reported a quarterly EPS of $4.08, missing analysts' expectations of $4.45, while its revenue increased by 12.9% compared to the previous year.
• The company announced a quarterly dividend of $2.21 per share, reflecting an annualized dividend yield of 2.6%, with a payout ratio of 38.30%.

Annex Advisory Services LLC decreased its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 69.8% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 18,018 shares of the healthcare conglomerate's stock after selling 41,553 shares during the period. Annex Advisory Services LLC's holdings in UnitedHealth Group were worth $5,621,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. Bayforest Capital Ltd lifted its position in UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after purchasing an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd grew its position in shares of UnitedHealth Group by 416.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock valued at $32,000 after purchasing an additional 50 shares during the last quarter. IAG Wealth Partners LLC acquired a new position in shares of UnitedHealth Group in the first quarter worth approximately $42,000. Copia Wealth Management purchased a new stake in UnitedHealth Group during the fourth quarter worth about $42,000. Finally, O Brien Wealth Partners LLC raised its stake in shares of UnitedHealth Group by 74.0% in the first quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate's stock valued at $46,000 after buying an additional 37 shares during the period. Institutional investors own 87.86% of the company's stock.

Wall Street Analyst Weigh In

UNH has been the topic of several recent research reports. Robert W. Baird reaffirmed an "underperform" rating and set a $198.00 price objective (down from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Wells Fargo & Company dropped their price objective on shares of UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating for the company in a report on Monday, August 4th. KeyCorp decreased their target price on shares of UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating for the company in a research note on Wednesday, July 30th. Barclays upped their price target on shares of UnitedHealth Group from $337.00 to $352.00 and gave the stock an "overweight" rating in a research note on Thursday, September 4th. Finally, Piper Sandler dropped their price target on UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating for the company in a research note on Wednesday, July 30th. Sixteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $358.95.

UnitedHealth Group Trading Up 1.4%

UNH traded up $4.80 during trading on Monday, reaching $341.49. The company had a trading volume of 8,883,715 shares, compared to its average volume of 13,010,308. The stock has a market cap of $309.27 billion, a P/E ratio of 14.80, a PEG ratio of 2.20 and a beta of 0.44. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The business has a 50 day simple moving average of $295.67 and a 200-day simple moving average of $363.56. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company's revenue for the quarter was up 12.9% on a year-over-year basis. During the same period last year, the business posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be issued a dividend of $2.21 per share. The ex-dividend date is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.6%. UnitedHealth Group's dividend payout ratio (DPR) is currently 38.30%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.